MarketWatch.com - Pre-Market Indications

Thursday, December 24, 2009

Mayo Clinic Study Shows Flu Shot Increases Hospitalization Risk in Children

Long Term Study Shows Flu Shot Increases Hospitalization Risk In Children

child-fluAn eight year study conducted at the Mayo Clinic, published by the American Thoracic Society suggests that there is a correlation between flu shots and risk of complications from influenza. The study evaluated every pediatric patient that was seen at the Mayo Clinic over the course of eight flu seasons to determine how much the flu shot prevented hospitalization from influenza in asthmatic children. ATS 2009, SAN DIEGOâ€" The inactivated flu vaccine does not appear to be effective in preventing influenza-related hospitalizations in children, especia lly the ones with asthma. In fact, children who get the flu vaccine are more at risk for hospitalization than their peers who do not get the vaccine, according to new research that will be presented on Tuesday, May 19, at the 105th International Conference of the American Thoracic Society in San Diego...


The CDC’s Advisory Committee on Immunization Practices (ACIP) and the American Academy
of Pediatrics (AAP) recommend annual influenza vaccination for all children aged six months to 18 years. The National Asthma Education and Prevention Program (3rd revision) also recommends annual flu vaccination of asthmatic children older than six months.

In order to determine whether the vaccine was effective in reducing the number of
hospitalizations that all children, and especially the ones with asthma, faced over eight consecutive flu
seasons, the researchers conducted a cohort study of 263 children who were evaluated at the Mayo Clinic in Minnesota from six months to 18 years of age, each of whom had had laboratory-confirmed influenza between 1996 to 2006. The investigators determined who had and had not received the flu vaccine, their asthma status and who did and did not require hospitalization. Records were reviewed for each subject with influenza-related illness for flu vaccination preceding the illness and hospitalization during that illness.

They found that children who had received the flu vaccine had three times the risk of
hospitalization, as compared to children who had not received the vaccine. In asthmatic children, there
was a significantly higher risk of hospitalization in subjects who received the TIV, as compared to those
who did not (p= 0.006). But no other measured factorsâ€"such as insurance plans or severity of asthmaâ€"appeared to affect risk of hospitalization.

NYSE Arca Morning Update - 08:30:00 ET

NYSE Arca Morning Update for Thursday, Dec 24, 2009 :

STOCKS TRADING ON NYSE Arca AT A PRICE 15% OR MORE AWAY FROM
THE PREVIOUS TRADE DAY'S CONSOLIDATED CLOSE PRICE (AS OF 08:30:00 ET)

Stock Wednesday's Close Current Price Pct Change Current NYSE ARCA Vol
QCOR $4.31 $5.31 23.3% 51,065
NCTY $7.04 $8.25 17.2% 2,100


10 MOST ACTIVE STOCKS ON NYSE ARCA AS OF 08:30:00 ET

BASED ON DOLLARS TRADED: | BASED ON SHARES TRADED:
Stock $ Volume Price PctChg | Stock Share Vol Price PctChg
SPY $34,573,252 $112.09 0.1% | C 353,608 $3.31 0.6%
GLD $26,643,133 $107.78 1.1% | ATHX 321,019 $5.47 4.2%
QQQQ $13,455,731 $45.61 0.1% | SPY 308,156 $112.09 0.1%
AAPL $9,411,897 $203.12 0.5% | QQQQ 294,900 $45.61 0.1%
IWM $1,813,872 $63.30 0.3% | GLD 246,901 $107.78 1.1%
FCX $1,793,590 $81.86 1.1% | TZA 122,000 $9.45 ( 0.5%)
ATHX $1,770,893 $5.47 4.2% | CGEN 121,792 $4.60 1.1%
GOOG $1,544,740 $612.63 0.1% | BAC 91,190 $15.24 0.4%
BAC $1,389,426 $15.24 0.4% | ANX 79,800 $0.21 1.2%
AMZN $1,370,887 $139.71 0.5% | FNM 53,200 $1.08 2.9%


Price changes may be affected by symbol splits and dividends.

Consolidated close price is the last print (excluding prints with trade
conditions) prior to 4PM ET.

This information is also updated on our web page every morning at 8:35ET:
http://www.tradearca.com/data/volume/daily_update.asp

This material is for informational purposes only.
NYSE Euronext and its affiliates ("NYSE Arca") are not soliciting any action based upon it.
This material is not to be construed as an offer to buy or sell any security in any jurisdiction where such an offer or solicitation would be illegal.
Any opinions expressed in this material are NYSE Arca opinions only.
NYSE Arca undertakes no obligation to update any of the information contained in this material in light of new information or future events.
THIS MATERIAL IS PROVIDED BY NYSE ARCA "AS IS" AND WITHOUT WARRANTIES EXPRESS OR IMPLIED.
NYSE ARCA DISCLAIMS ALL WARRANTIES INCLUDING THE IMPLIED WARRANTIES OF MERCHANTIBILITY, TITLE, AND FITNESS FOR A PARTICULAR PURPOSE AS TO THIS MATERIAL.
IN NO EVENT SHALL NYSE ARCA BE LIABLE FOR DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER (INCLUDING BUT NOT LIMITED TO, LOST PROFITS, TRADING LOSSES AND DAMAGES THAT MAY RESULT FROM THE USE
OF THIS MATERIAL, ANY DELAY OR INTERRUPTION OF SERVICE OR OMISSIONS OR INACCURACIES IN THE MATERIAL) WITH RESPECT TO THIS MATERIAL.

Copyright [2009] by NYSE Euronext. All rights reserved. Reproduction and redistribution prohibited without prior express consent.

Pre Market Movers - Futures Trading - Nasdaq - NYSE

Subscribe to "The $t0ckman" via email

Enter your email address:

Delivered by FeedBurner